Originally written by ZRT Laboratory author. Reproduced with permission. Last reviewed: May 2026.
Vitex agnus-castus — commonly known as chasteberry or chaste tree berry — is one of the most widely used and well-researched botanical remedies for female hormone imbalance. With a history of use spanning centuries, and a growing body of clinical trial evidence, Vitex has earned a legitimate place in the management of menstrual cycle disturbances, PMS, PMDD, and some symptoms of the menopausal transition.
This article explains how Vitex works, what the clinical evidence shows, and when it may be an appropriate option for women with hormone-related symptoms.
What Is Vitex Agnus-Castus?
Vitex agnus-castus is a flowering shrub native to the Mediterranean and Central Asia. Its dried berries have been used medicinally since antiquity. During the Middle Ages, the berries were used in monasteries as a condiment believed to suppress libido — giving rise to names such as monk’s pepper, Abraham’s balm, and chasteberry. In the mid-twentieth century, Vitex was commonly prescribed for nervousness, mood disturbances, and menstrual irregularities. Today, its primary clinical applications are in regulating menstrual cycles, reducing PMS and PMDD symptoms, and managing prolactin-related hormonal imbalances.
The active constituents of Vitex include essential oils (monoterpenes, diterpenes, and sesquiterpenes), flavonoids such as casticin and vitexin, and iridoid glycosides including aucubin and agnoside. The synergistic activity between these compounds is thought to contribute to the herb’s clinical effects, and standardised extracts have been developed to ensure consistent dosing in clinical research.
How Does Vitex Work? The Hormonal Mechanism
Prolactin Inhibition via Dopamine Receptors
The primary mechanism through which Vitex exerts its hormonal effects is via dopaminergic activity. Vitex contains constituents that bind to dopamine D2 receptors in the anterior pituitary gland, inhibiting the secretion of prolactin — the hormone primarily associated with breast milk production but also involved in regulating the menstrual cycle.
Prolactin is secreted in response to eating, ovulation, low dopamine levels, and stress. When prolactin is chronically elevated — a condition known as hyperprolactinemia — it suppresses the hormonal signals needed for regular ovulation and adequate progesterone production in the luteal phase. This creates a pattern of luteal phase defect: insufficient progesterone after ovulation, which can cause irregular cycles, heavy or prolonged bleeding, difficulty conceiving, and the hormonal imbalances that drive PMS and PMDD.
By reducing prolactin, Vitex helps restore the conditions needed for regular ovulation and adequate luteal phase progesterone production — addressing the root hormonal cause of many menstrual cycle disturbances.
Progesterone and the Luteal Phase
Insufficient luteal phase progesterone is a common denominator in a wide range of menstrual cycle disturbances, whether cycles are ovulatory or anovulatory. Inadequate progesterone impairs endometrial development (affecting implantation), shortens the luteal phase, and creates the oestrogen-dominant hormonal environment associated with PMS, breast tenderness, bloating, mood instability, and heavy periods.
By normalising prolactin and supporting corpus luteum function, Vitex helps restore progesterone levels in the luteal phase — addressing the underlying hormonal imbalance rather than simply managing symptoms.
Understanding your own hormonal pattern across the full menstrual cycle is the most reliable way to confirm whether luteal phase progesterone deficiency is present. Our 1 Month Hormone Test for Women maps oestrogen and progesterone across all 28 days of your cycle using daily dried urine samples — providing a detailed picture of ovulation timing, luteal phase adequacy, and overall cycle health.
Clinical Evidence: Vitex for Menstrual Problems and High Prolactin
Two well-designed clinical studies have examined the effect of Vitex on hyperprolactinemia specifically.
In the first study, a 20 mg capsule of Vitex dried fruit extract was compared with placebo in 52 women with elevated prolactin, administered daily for three months. Compared with placebo, Vitex significantly reduced prolactin concentrations, lengthened the luteal phase by five days, normalised mid-luteal progesterone levels, and increased oestradiol.
The second study compared 40 mg of Vitex dried fruit extract daily with bromocriptine (5 mg) — a pharmaceutical medication used to treat high prolactin — in 80 women divided into two groups: those with mild prolactin elevation and those with cyclic breast pain (mastalgia). After three months, both treatments produced significant reductions in prolactin and significant improvements in mastalgia, with no meaningful difference in efficacy between the two. However, bromocriptine was associated with nausea and vomiting, while Vitex produced no adverse effects. Notably, two women in the Vitex group became pregnant during the trial — suggesting the herb had additional beneficial effects on ovulation and corpus luteum function beyond those of bromocriptine.
Clinical Evidence: Vitex for PMS
Premenstrual syndrome (PMS) affects up to 90% of women at some point in their reproductive lives. Symptoms — including mood swings, irritability, breast tenderness, food cravings, fatigue, depression, headaches, and bloating — typically occur in the week or two before menstruation and are driven by the hormonal fluctuations of the late luteal phase.
Multiple randomised controlled trials have evaluated Vitex as a treatment for PMS, consistently finding it superior to placebo. Women with mild to moderate PMS symptoms — including breast fullness, bloating, headache, menstrual pain, sleep disturbance, irritability, and mood changes — experienced significant improvement with Vitex therapy compared with placebo. Oral doses in these trials typically ranged from 20 to 40 mg of dried, ethanol-extracted herb, administered either daily throughout the cycle or in the week before menstruation, over a three-month course. Most benefit was observed by the third month of treatment.
Clinical Evidence: Vitex for PMDD
Premenstrual dysphoric disorder (PMDD) is a more severe form of PMS characterised by debilitating psychological symptoms including intense anger, anxiety, depression, poor concentration, and sleep disturbance, alongside physical PMS symptoms. PMDD significantly impairs daily functioning and quality of life.
Two clinical trials compared Vitex directly with fluoxetine (an SSRI antidepressant marketed for PMDD) over eight weeks. Both trials concluded that Vitex was a valid alternative to fluoxetine for the physical symptoms of PMDD, though fluoxetine may be modestly more effective for the psychological symptoms. For women who prefer to avoid pharmaceutical antidepressants, Vitex represents a clinically supported botanical alternative for the physical dimension of PMDD.
Clinical Evidence: Vitex for Menopausal Symptoms
Although Vitex is most commonly used in premenopausal women, it has also been studied as a therapeutic option for menopausal symptoms. A Korean randomised controlled trial followed two groups of women over eight weeks using the Greene Climacteric Scale — a validated questionnaire for menopausal symptom severity. One group received 30 mg of Vitex extract twice daily; the other received placebo.
At the end of the trial, Vitex significantly reduced scores for anxiety and vasomotor dysfunction (hot flushes and night sweats) compared with placebo. Depression, somatic symptoms (pain and fatigue), and sexual dysfunction did not show statistically significant differences from placebo. Vitex may therefore offer modest benefit for anxiety and vasomotor symptoms during the menopausal transition, particularly for women who prefer botanical approaches.
Safety Profile and Contraindications
Vitex has a well-established safety profile across clinical trials. Adverse events — including mild nausea, acne, urticaria, and headache — were infrequent and mild, occurring at rates comparable to or lower than placebo in most studies.
Important contraindications and cautions include:
- Oral contraceptives: Vitex may interfere with the effectiveness of hormonal contraceptives and should not be used concurrently without medical guidance.
- Pregnancy: Vitex is generally contraindicated during pregnancy.
- Breastfeeding: Despite a historical association with supporting lactation, Vitex may suppress prolactin and is generally contraindicated during breastfeeding.
- Dopaminergic medications: Because Vitex acts on dopamine receptors, it may interact with medications that affect dopamine signalling.
When Is Vitex Most Likely to Help?
Vitex is most likely to be beneficial when symptoms and laboratory testing suggest luteal phase progesterone deficiency driven by elevated prolactin or inadequate corpus luteum function. It is less likely to be effective when hormonal imbalance has other causes — such as primary ovarian insufficiency, thyroid dysfunction, or adrenal dysregulation — which is why hormone testing before and during botanical treatment is valuable.
Our Advanced Female Wellness Test provides a comprehensive assessment of oestrogen, progesterone, testosterone, DHEA, cortisol, and thyroid markers — with a specialist doctor’s report to help identify the specific hormonal drivers of your symptoms and guide the most appropriate treatment approach.
Frequently Asked Questions
What is Vitex agnus-castus used for?
Vitex agnus-castus is primarily used to support female hormone balance, particularly in conditions associated with elevated prolactin and low luteal phase progesterone. Clinical evidence supports its use for reducing PMS symptoms, alleviating PMDD (particularly physical symptoms), normalising menstrual cycle regularity, and reducing some menopausal symptoms including anxiety and hot flushes.
How does Vitex affect progesterone?
Vitex does not contain progesterone and does not directly supply it. Instead, it works by binding to dopamine D2 receptors in the pituitary gland, reducing prolactin secretion. Lower prolactin allows for more consistent ovulation and better corpus luteum function, which in turn supports adequate progesterone production in the luteal phase of the menstrual cycle.
How long does Vitex take to work?
Clinical trials consistently show that most benefit from Vitex is observed after three months of continuous use. Some improvement may be noticed earlier, but the full hormonal effect — particularly on luteal phase progesterone and cycle regularity — typically requires at least two to three complete menstrual cycles.
Can Vitex be used during menopause?
Yes, with some evidence of benefit. A randomised controlled trial found that Vitex significantly reduced anxiety and vasomotor symptoms (hot flushes and night sweats) compared with placebo in perimenopausal women over eight weeks. It did not show significant benefit for depression, pain, fatigue, or sexual dysfunction in this study.
Is Vitex safe to take long-term?
Vitex has a good safety profile in clinical trials of up to three months. Long-term safety data beyond this period is limited. It is generally well tolerated, with mild and infrequent adverse effects. Women with hormone-sensitive conditions, those taking hormonal contraceptives, or those who are pregnant or breastfeeding should consult a healthcare provider before using Vitex.
How do I know if Vitex is right for me?
Vitex is most likely to be beneficial when symptoms suggest luteal phase progesterone deficiency or elevated prolactin — including short luteal phases, PMS, irregular cycles, breast tenderness, and difficulty conceiving. Comprehensive hormone testing can confirm whether these patterns are present and help identify whether Vitex or another intervention is most appropriate for your specific hormonal profile.
Our Comprehensive Female Saliva Hormone Profile measures eight key hormones using LCMS-validated saliva analysis — providing the detailed hormonal picture needed to determine whether Vitex is likely to be an effective option for your symptoms.
References
[1] Mills S, Bone K. Principles and Practice of Phytotherapy. Churchill Livingstone, 2000.
[2] Milewicz A, et al. Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Arzneimittelforschung. 1993;43:752–6.
[3] Kilicdag EB, et al. Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia. Int J Gynaecol Obstet. 2004;85:292–293.
[4] Ma L, et al. Treatment of moderate to severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Gynecol Endocrinol. 2010;26:612–6.
[5] He Z, et al. Treatment for premenstrual syndrome with Vitex agnus castus. Maturitas. 2009;63:99–103.
[6] Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract. BMJ. 2001;322:134–137.
[7] Van Die MD, et al. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med. 2013;79:562–575.
[8] Naseri R, et al. Comparison of Vitex agnus-castus extracts with placebo in reducing menopausal symptoms. Korean J Family Med. 2019;40:362–367.
[9] Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol. 2003;8:191–5.
[10] Wuttke W, et al. Chaste tree (Vitex agnus-castus) pharmacology and clinical indications. Phytomedicine. 2003;10:348–57.
Originally written by ZRT Laboratory author. Reproduced with permission. Last reviewed: May 2026.